Rouquette Lassalle Isabelle
Service d'anatomie pathologique, IUCT Oncopôle, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France.
Ann Pathol. 2016 Jan;36(1):34-43. doi: 10.1016/j.annpat.2015.11.008. Epub 2016 Jan 5.
In the recently published 2015 World Health Organization (WHO) classification of tumors of the lungs, all neuroendocrine tumors of the lungs are presented for the first time in one single chapter. In this classification, high-grade small cell lung cancer (SCLC) and large cell neuroendocrine carcinoma (LCNEC) are differentiated from intermediate grade atypical carcinoids (AC) and low-grade typical carcinoids as well as from preinvasive lesion diffuse neuroendocrine hyperplasia DIPNECH. In the 2004 WHO classification, SCLC and carcinoids each had a separate chapter and LCNEC was listed in the chapter on large cell carcinoma of the lungs. The new WHO classification also gives some recommendations for the diagnosis on small biopsies. This review describes morphological, immunohistochemical, and genomic characteristic of these tumors according to the new classification.
在最近发布的2015年世界卫生组织(WHO)肺肿瘤分类中,所有肺神经内分泌肿瘤首次在单独一章中呈现。在该分类中,高级别小细胞肺癌(SCLC)和大细胞神经内分泌癌(LCNEC)与中级别非典型类癌(AC)、低级别典型类癌以及侵袭前病变弥漫性神经内分泌增生(DIPNECH)区分开来。在2004年WHO分类中,SCLC和类癌各有单独一章,而LCNEC列于肺大细胞癌一章中。新的WHO分类也给出了一些关于小活检诊断的建议。本综述根据新分类描述了这些肿瘤的形态学、免疫组化和基因组特征。